These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7791555)

  • 1. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease.
    Christiansen P; Schlosser A; Henriksen O
    Magn Reson Imaging; 1995; 13(3):457-62. PubMed ID: 7791555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium.
    Christiansen P; Toft P; Larsson HB; Stubgaard M; Henriksen O
    Magn Reson Imaging; 1993; 11(6):799-806. PubMed ID: 8371635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo relaxation of N-acetyl-aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study.
    Gideon P; Henriksen O
    Magn Reson Imaging; 1992; 10(6):983-8. PubMed ID: 1461096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
    Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.
    Salvan AM; Vion-Dury J; Confort-Gouny S; Nicoli F; Lamoureux S; Cozzone PJ
    Invest Radiol; 1997 Aug; 32(8):485-95. PubMed ID: 9258737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
    Simmons A; Smail M; Moore E; Williams SC
    Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
    Block W; Träber F; Kuhl CK; Fric M; Keller E; Lamerichs R; Rink H; Möller HJ; Schild HH
    Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1, T2, and concentrations of brain metabolites in neonates and adolescents estimated with H-1 MR spectroscopy.
    Toft PB; Christiansen P; Pryds O; Lou HC; Henriksen O
    J Magn Reson Imaging; 1994; 4(1):1-5. PubMed ID: 7908545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].
    Engelhardt E; Moreira DM; Laks J; Marinho VM; Rozenthal M; Oliveira AC
    Arq Neuropsiquiatr; 2001 Dec; 59(4):865-70. PubMed ID: 11733829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy.
    Toft PB; Leth H; Lou HC; Pryds O; Henriksen O
    J Magn Reson Imaging; 1994; 4(5):674-80. PubMed ID: 7981512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.
    Jessen F; Traeber F; Freymann N; Maier W; Schild HH; Heun R; Block W
    Dement Geriatr Cogn Disord; 2005; 20(2-3):178-83. PubMed ID: 16024934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.
    Tunc-Skarka N; Weber-Fahr W; Hoerst M; Meyer-Lindenberg A; Zink M; Ende G
    Neuroimage; 2009 Nov; 48(3):525-31. PubMed ID: 19573608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance spectroscopy findings in photosensitive idiopathic generalized epilepsy.
    Aydin-Ozemir Z; Terzibasioglu E; Altindag E; Sencer S; Baykan B
    Clin EEG Neurosci; 2010 Jan; 41(1):42-9. PubMed ID: 20307015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.